Jingrong Cui

2.2k total citations
77 papers, 2.0k citations indexed

About

Jingrong Cui is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jingrong Cui has authored 77 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Jingrong Cui's work include Natural product bioactivities and synthesis (13 papers), Ubiquitin and proteasome pathways (12 papers) and Synthesis and biological activity (11 papers). Jingrong Cui is often cited by papers focused on Natural product bioactivities and synthesis (13 papers), Ubiquitin and proteasome pathways (12 papers) and Synthesis and biological activity (11 papers). Jingrong Cui collaborates with scholars based in China, Hong Kong and Japan. Jingrong Cui's co-authors include Ruiqing Wang, Pengfei Tu, Runtao Li, Bo Xu, Zemei Ge, Wei Guo, Yuying Zhao, Shao‐Qing Cai, Chao‐Mei Ma and Masao Hattori and has published in prestigious journals such as Biomaterials, Analytical Biochemistry and Molecules.

In The Last Decade

Jingrong Cui

77 papers receiving 1.9k citations

Peers

Jingrong Cui

ONCOL

Manuel Medarde Spain

Д. В. Корчагина Russia

Midori A. Arai Japan

Urszula Krajewska Poland

Masayoshi Ando Japan

Xiaoan Wen China

Yuka Nakanishi United States

Ferda Arı Türkiye

Marek Różalski Poland

Prasad Dandawate United States

Manuel Medarde Spain

Jingrong Cui

1.2k ×1.3

1.6k ×2.1

405 ×1.0

ONCOL

376 ×1.3

91 ×0.4

Citations per year, relative to Jingrong Cui Jingrong Cui (= 1×) peers Manuel Medarde

Countries citing papers authored by Jingrong Cui

Since Specialization

Citations

This map shows the geographic impact of Jingrong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingrong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingrong Cui more than expected).

Fields of papers citing papers by Jingrong Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingrong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingrong Cui. The network helps show where Jingrong Cui may publish in the future.

Co-authorship network of co-authors of Jingrong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jingrong Cui. A scholar is included among the top collaborators of Jingrong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingrong Cui. Jingrong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Qinghua, Qian Yi, Qingying Zhang, et al.. (2021). Oleanane-type saponins and prosapogenins from Albizia julibrissin and their cytotoxic activities. Phytochemistry. 185. 112674–112674. 4 indexed citations

Han, Liqiang, Ridong Li, Bo Xu, et al.. (2017). Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors. Bioorganic & Medicinal Chemistry. 25(15). 4031–4044. 14 indexed citations

Han, Liqiang, Xia Yuan, Xingyu Wu, et al.. (2016). Urea-containing peptide boronic acids as potent proteasome inhibitors. European Journal of Medicinal Chemistry. 125. 925–939. 26 indexed citations

Huang, Wei, Xia Yuan, Bo Xu, et al.. (2015). YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways. Journal of Cancer. 6(4). 319–326. 10 indexed citations

Zhang, Mei, Xia Yuan, Bo Xu, et al.. (2015). Anticancer Effect of a Novel Proteasome Inhibitor, YSY01A, via G2/M Arrest in PC-3M Cells in vitro and in vivo. Journal of Cancer. 6(8). 701–708. 3 indexed citations

Zhang, Jianmei, et al.. (2013). Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC–DAD: A cocktail approach. Journal of Chromatography B. 923-924. 29–36. 12 indexed citations

Cui, Jingrong. (2010). Relationship between the initiation,development and therapy of tumor and inflammation. Zhongguo xin yao zazhi. 3 indexed citations

Cui, Jingrong. (2009). Inhibition of Diacetyldianhydrogalactitol on Ornithine Decarboxylase Activity and Its Possible Mechanisms. Zhōnghuá yàoxué zázhì. 1 indexed citations

Zhang, Jinchao, Yaping Li, Jing Sun, et al.. (2009). Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes. European Journal of Medicinal Chemistry. 44(11). 4772–4777. 5 indexed citations

10.

Chen, Wenjing, et al.. (2009). Capillary electrophoresis for screening of 20S proteasome inhibitors. Analytical Biochemistry. 394(1). 62–67. 13 indexed citations

11.

Wang, Siting, et al.. (2009). Determination of Anti-Tumor Agent TM208, 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride, in Rats by LC. Chromatographia. 70(11-12). 1721–1725. 4 indexed citations

12.

Li, Min, et al.. (2008). Induction of apoptosis accompanying with G1 phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene. Cancer Letters. 262(1). 114–122. 25 indexed citations

13.

Jiang, Xiaomei, et al.. (2007). Studies on the metabolism of 4‐methylpiperazine‐1‐carbodithioc acid 3‐cyano‐3,3‐ diphenylpropyl ester hydrochloride in rat bile by high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(10). 1599–1605. 10 indexed citations

14.

Yang, Huayu, Wei Guo, Bo Xu, Min Li, & Jingrong Cui. (2007). Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma. Anti-Cancer Drugs. 18(10). 1133–1137. 31 indexed citations

15.

Cui, Jingrong. (2007). Protection of 1-hydroxy-2, 3, 5-trimethoxyxanthone on acute lung injury of mice induced by lipopolysaccharide. Zhongcaoyao. 2 indexed citations

16.

Zhang, Jinchao, et al.. (2006). Synthesis and antitumor activity of iodo-bridged binuclear platinum complex. Chinese Science Bulletin. 51(8). 911–917. 2 indexed citations

17.

Liang, Hong, et al.. (2005). An antitumor compound julibroside J28 from Albizia julibrissin. Bioorganic & Medicinal Chemistry Letters. 15(20). 4493–4495. 50 indexed citations

18.

Ma, Chao‐Mei, Shao‐Qing Cai, Jingrong Cui, et al.. (2005). The cytotoxic activity of ursolic acid derivatives. European Journal of Medicinal Chemistry. 40(6). 582–589. 207 indexed citations

19.

Liu, Bo, Chunhao Yang, Guangyu Xu, et al.. (2005). Syntheses of quinolone hydrochloride enantiomers from synthons (R)- and (S)-2-methylpiperazine. Bioorganic & Medicinal Chemistry. 13(7). 2451–2458. 5 indexed citations

20.

Xu, Min‐Juan, et al.. (2005). Embelin Derivatives and Their Anticancer Activity through Microtubule Disassembly. Planta Medica. 71(10). 944–948. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact